Contact Us
Use this form to send us a message, and we’ll get back to you shortly.
Pharma companies are growing fast, but hiring has not kept pace. The result is a talent crunch across regulatory affairs, pharmacovigilance, biologics, AI drug discovery, and manufacturing leadership.
But talk to any hiring leader in pharma right now and you will hear the same thing: finding the right people has never been harder.
This is no longer just a hiring challenge; it is becoming a business challenge.
Why pharma talent is so hard to find
The issue is not that talent does not exist.
The issue is that the industry has evolved faster than the talent pipeline.
India’s pharma sector is expanding quickly and is projected to reach $130 billion by 2030. Growth in biosimilars, GCCs, and AI-driven drug discovery is increasing demand for specialist skills. At the same time, universities and training pipelines are still catching up with today’s technical requirements.
That means employers are competing for a much smaller pool of people with the right mix of scientific depth, regulatory knowledge, and digital capability.
What is driving the shortage
Industry growth is outpacing supply
Demand is rising across pharma, biotech, and life sciences, especially in biologics, pharmacovigilance, and regulatory affairs.
New technologies are creating new roles
AI drug discovery, biosimilars manufacturing, cell and gene therapy, and digital transformation have created specialist roles that need both technical and scientific skills.
GCCs are changing the market
Global Capability Centres are offering stronger salaries, flexible working, and wider global exposure, which makes them attractive to experienced professionals.
The best candidates are passive
The people employers most want to hire are usually already employed. They are not applying to job ads, so hiring now depends on relationships, talent mapping, and proactive outreach.
The best candidates are passive
The people employers most want to hire are usually already employed. They are not applying to job ads, so hiring now depends on relationships, talent mapping, and proactive outreach. That means strong hiring in this market depends on relationships, talent mapping, and proactive outreach, not just posting vacancies online.
The roles hardest to fill
Regulatory affairs
People with experience in USFDA, EMA, and MHRA submissions are in short supply. These are highly specialised roles that usually take years to build.
Biologics and biosimilars
Talent in cell line development, bioprocessing, fermentation, and recombinant protein work is still limited. Strong candidates are being pursued by pharma, biotech, and GCCs at the same time.
AI and digital health
This is one of the most competitive areas in the market. Employers want people who understand both AI and Pharma, and that combination is still rare.
What pharma hiring will look like next
The pressure on talent will not ease soon.
Cell and gene therapy will create new manufacturing needs. AI-driven drug discovery will become more common. Global regulatory expertise will remain in demand. CDMO growth will continue to increase hiring across operations, engineering, and quality. Sustainability will also create new roles in green chemistry, process engineering, and EHS.
For hiring leaders, that means workforce planning needs to happen earlier and more strategically.
The pharma talent crisis is real, but it is also predictable. The companies that will win over the next five years are the ones building talent strategy before roles become urgent.
